跳至主要内容
临床试验/NCT06896448
NCT06896448招募中不适用

Innovative OSA Screening in Head and Neck Cancer Patients With the Apneal App

University Hospital, Caen1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2025年9月16日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
20
试验地点
1
主要终点
Measurement of the rate of usable collected data at 6 months after treatment, with an interim analysis after the first consultation and initial recording, meaning a given Apnea-Hypopnea Index (AHI) from at least 6 hours of overnight recording

研究概览

简要总结

Obstructive sleep apnea syndrome is a common but often underdiagnosed condition, with significant impacts on quality of life, such as fatigue, attention disorders, and an increased risk of heart attack or stroke. Structural changes in the head and neck region appear to contribute to the onset or worsening of this condition.

To improve patients' quality of life, early diagnosis is essential. Currently, diagnosis relies on expensive devices, often associated with long waiting times. To address these challenges, an innovative solution is proposed: a smartphone application enabling a simple and accessible diagnosis. This application is currently under validation and has not yet been commercialized.

The purpose of the study is to determine whether this smartphone application can be used in clinical practice for patients with a head and neck lesion to diagnose sleep apnea syndrome and to assess its progression during the medical care. This study is for patients who present a head and neck lesion currently under evaluation in our department at Caen University Hospital.

This research will be integrated into routine follow-up for a period of six months.

The medical device used in this study, Apneal, is a smartphone application currently undergoing validation for the rapid diagnosis of sleep apnea syndrome. Its use is simple: the smartphone is placed in airplane mode and secured to the chest overnight. Using the phone's built-in sensors, respiratory sleep data is collected and analyzed.

As part of the initial assessment, a dedicated sleep consultation is included, during which a few questionnaires are completed, followed by an overnight sleep recording using the Apneal application. This will be conducted at the beginning of the care during the assessment phase and again six months after the completion of any potential treatment.

Depending on the results, if they are inconclusive, an additional sleep recording may be required using a ventilatory polygraphy device.

This study involves only two overnight recordings with a smartphone secured to the chest, which we will set up during the consultation.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adult patients undergoing diagnostic workup for a lesion suspected to be a head and neck cancer, followed by confirmation of the malignant nature of the lesion. The following locations will be included: the nasopharynx, nasal cavities, sinuses, oral cavity, oropharynx, hypopharynx, larynx, and parotid gland.
  • •The collection of the informed consent signature is required.
  • •The patient must be affiliated with the social security system.

排除标准

  • •Minor patients, or those under judicial protection, guardianship, or curators.
  • •Lack of confirmation of the malignant nature of the lesion.
  • •Diagnosis of metastatic cancer.
  • •Known history of obstructive sleep apnea syndrome (OSAS) or previously treated head and neck cancer.

研究组 & 干预措施

Patients with head and neck cancers

Experimental

干预措施: Specialized sleep consultation and overnight recording using the APNEAL application (Diagnostic Test)

结局指标

主要结局

Measurement of the rate of usable collected data at 6 months after treatment, with an interim analysis after the first consultation and initial recording, meaning a given Apnea-Hypopnea Index (AHI) from at least 6 hours of overnight recording

时间窗: 8 months

Study the feasibility of screening for obstructive sleep apnea syndrome (OSAS) in clinical practice among patients with head and neck cancer using the Apneal application, which is currently under validation The patient is treated during around 2 months and the night recording will be at 3 and 6 months after the end of the treatment The number of the recording nights with at least 4 hours records will be calculated

次要结局

  • Measurement of the evolution of the AHI score during patient management, comparing the first recording with the second one performed six months after treatment completion(8 months)
  • Measurement of the evolution of quality of life criteria by comparing the initial questionnaires completed during the first consultation with those completed 6 months after treatment(8 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验